Skip to main content
All lobbying filings

ARNOLD & PORTER KAYE SCHOLER LLP

Lobbying for RECORDATI RARE DISEASES INC. · Pharmaceutical manufacturer of treatments for rare and ultra-rare diseases.

 Filing 2nd Quarter - Report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 17, 2026
Income
$60,000.00
What the client paid this registrant for the period.
Client based in
New Jersey

Official filing document

 Lobbying activity 3
Medicare/Medicaid

Issues related to improving access to needed therapies for rare and ultra-rare diseases in the United States. Issues related to drug pricing, including most favored nation (MFN) policies.

Health Issues

Issues related to improving access to needed therapies for rare and ultra-rare diseases in the United States. Issues related to drug pricing, including most favored nation (MFN) policies.

Trade (domestic/foreign)

Issues related to trade and tariff policies pertaining to therapies for rare and ultra-rare diseases in the United States.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem